Stockreport

Co-Diagnostics, Inc. Announces Elimination of Debt, Additional Capital Infusion

Co-Diagnostics, Inc.  (CODX) 
US:NASDAQ Investor Relations: ir.codiagnostics.com/investor-relations
PDF Transaction included $3M of preferred shares, and the elimination of $2M of debt SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (Nasda [Read more]